Literature DB >> 22342763

Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

Matthew Benskey1, Bahareh Behrouz, Johan Sunryd, Samuel S Pappas, Seung-Hoon Baek, Marianne Huebner, Keith J Lookingland, John L Goudreau.   

Abstract

Hypothalamic tuberoinfundibular dopamine (TIDA) neurons remain unaffected in Parkinson disease (PD) while there is significant degeneration of midbrain nigrostriatal dopamine (NSDA) neurons. A similar pattern of susceptibility is observed in acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse and rotenone rat models of degeneration. It is not known if the resistance of TIDA neurons is a constitutive or induced cell-autonomous phenotype for this unique subset of DA neurons. In the present study, treatment with a single injection of MPTP (20 mg/kg; s.c.) was employed to examine the response of TIDA versus NSDA neurons to acute injury. An acute single dose of MPTP caused an initial loss of DA from axon terminals of both TIDA and NSDA neurons, with recovery occurring solely in TIDA neurons by 16 h post-treatment. Initial loss of DA from axon terminals was dependent on a functional dopamine transporter (DAT) in NSDA neurons but DAT-independent in TIDA neurons. The active metabolite of MPTP, 1-methyl, 4-phenylpyradinium (MPP+), reached higher concentration and was eliminated slower in TIDA compared to NSDA neurons, which indicates that impaired toxicant bioactivation or distribution is an unlikely explanation for the observed resistance of TIDA neurons to MPTP exposure. Inhibition of protein synthesis prevented TIDA neuron recovery, suggesting that the ability to recover from injury was dependent on an induced, rather than a constitutive cellular mechanism. Further, there were no changes in total tyrosine hydroxylase (TH) expression following MPTP, indicating that up-regulation of the rate-limiting enzyme in DA synthesis does not account for TIDA neuronal recovery. Differential candidate gene expression analysis revealed a time-dependent increase in parkin and ubiquitin carboxyl-terminal hydrolase-L1 (UCH-L1) expression (mRNA and protein) in TIDA neurons during recovery from injury. Parkin expression was also found to increase with incremental doses of MPTP. The increase in parkin expression occurred specifically within TIDA neurons, suggesting that these neurons have an intrinsic ability to up-regulate parkin in response to MPTP-induced injury. These data suggest that TIDA neurons have a compensatory mechanism to deal with toxicant exposure and increased oxidative stress, and this unique TIDA neuron phenotype provides a platform for dissecting the mechanisms involved in the natural resistance of central DA neurons following toxic insult.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342763      PMCID: PMC3363356          DOI: 10.1016/j.neuro.2012.02.001

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  38 in total

1.  Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA.

Authors:  S Kitayama; S Shimada; G R Uhl
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

2.  Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain.

Authors:  R Revay; R Vaughan; S Grant; M J Kuhar
Journal:  Synapse       Date:  1996-02       Impact factor: 2.562

3.  The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

Authors:  S G Speciale; C L Liang; P K Sonsalla; R H Edwards; D C German
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

4.  Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.

Authors:  P Chan; L E DeLanney; I Irwin; J W Langston; D Di Monte
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

5.  The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

Authors:  H C Hung; E H Lee
Journal:  Brain Res Mol Brain Res       Date:  1996-09-05

6.  Mortality in patients with Parkinson's disease.

Authors:  L Wermuth; E N Stenager; E Stenager; J Boldsen
Journal:  Acta Neurol Scand       Date:  1995-07       Impact factor: 3.209

7.  Trophic factor production by reactive astrocytes in injured brain.

Authors:  J P Schwartz; J G Sheng; K Mitsuo; S Shirabe; N Nishiyama
Journal:  Ann N Y Acad Sci       Date:  1993-05-28       Impact factor: 5.691

8.  Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

Authors:  R R Gainetdinov; F Fumagalli; S R Jones; M G Caron
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

9.  Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.

Authors:  M Del Zompo; M P Piccardi; S Ruiu; M Quartu; G L Gessa; A Vaccari
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  L Y Zang; H P Misra
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

View more
  9 in total

1.  Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.

Authors:  Hae-Young Hawong; Joseph R Patterson; Brittany M Winner; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2015-07-02       Impact factor: 3.252

2.  The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

Authors:  Matthew J Benskey; Fredric P Manfredsson; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2014-11-20       Impact factor: 4.294

3.  Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Authors:  Tyrell J Simkins; Kelly L Janis; Alison K McClure; Bahareh Behrouz; Samuel S Pappas; Andreas Lehner; Norbert E Kaminski; John L Goudreau; Keith J Lookingland; Barbara L F Kaplan
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

4.  Manganese Intoxication Recovery and the Expression Changes of Park2/Parkin in Rats.

Authors:  Yu-Min Cao; Xi-Min Fan; Jie Xu; Jie Liu; Qi-Yuan Fan
Journal:  Neurochem Res       Date:  2021-11-28       Impact factor: 3.996

5.  FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Authors:  Joseph R Patterson; Elizabeth J Kim; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2016-08-24       Impact factor: 3.252

Review 6.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

7.  Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

Authors:  Matthew Benskey; Ki Yong Lee; Kevin Parikh; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2013-05-01       Impact factor: 4.294

8.  Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP.

Authors:  Brittany M Winner; Harue Zhang; McKenzie M Farthing; Lalitha M Karchalla; Keith J Lookingland; John L Goudreau
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

9.  Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.

Authors:  Urmas Roostalu; Casper B G Salinas; Ditte D Thorbek; Jacob L Skytte; Katrine Fabricius; Pernille Barkholt; Linu M John; Vanessa Isabell Jurtz; Lotte Bjerre Knudsen; Jacob Jelsing; Niels Vrang; Henrik H Hansen; Jacob Hecksher-Sørensen
Journal:  Dis Model Mech       Date:  2019-11-22       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.